Product Description: Anticancer agent 265 (compound 1) is an anticancer compound. Anticancer agent 265 exhibits in vitro anticancer activity against three human bone cancer lines, U2OS, Saos-2, and GC9811, with IC50 values of 13.1, 11.7, and 14.6 μM, respectively[1].
Formula: C30H35N5O3
References: [1]G Lv, et al. Synthesis, crystal structure, anti-bone cancer activity and molecular docking investigations of the heterocyclic compound 1-((2S, 3S)-2-(benzyloxy) pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl) piperazin-1-yl) phenyl)-1H-1, 2, 4-triazol-5 (4H)-one. Journal of Structural Chemistry 60.7 (2019): 1173-1179.
CAS Number: 184177-83-1
Molecular Weight: 513.63
Compound Purity: 99.74
Research Area: Cancer
Target: Drug Derivative